Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism

Hepatology. 2013 Dec;58(6):1881-4. doi: 10.1002/hep.26582. Epub 2013 Oct 18.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Chalcones / therapeutic use*
  • Fatty Liver / drug therapy*
  • Humans
  • Non-alcoholic Fatty Liver Disease
  • PPAR alpha / agonists*
  • PPAR delta / agonists*
  • Propionates / therapeutic use*

Substances

  • 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid
  • Chalcones
  • PPAR alpha
  • PPAR delta
  • Propionates